These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 35469137)

  • 1. Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects.
    Perrotta FM; Scriffignano S; Ciccia F; Lubrano E
    Open Access Rheumatol; 2022; 14():57-66. PubMed ID: 35469137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
    Braun J; Kiltz U; Baraliakos X
    Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JAK Inhibitors for the Treatment of Axial Spondyloarthritis.
    Klavdianou K; Papagoras C; Baraliakos X
    Mediterr J Rheumatol; 2023 Jun; 34(2):129-138. PubMed ID: 37654636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
    Burmester GR; Stigler J; Rubbert-Roth A; Tanaka Y; Azevedo VF; Coombs D; Lagunes I; Lippe R; Wung P; Gensler LS
    Rheumatol Ther; 2024 Jun; 11(3):737-753. PubMed ID: 38683479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor-α inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation.
    Corbett M; Soares M; Jhuti G; Rice S; Spackman E; Sideris E; Moe-Byrne T; Fox D; Marzo-Ortega H; Kay L; Woolacott N; Palmer S
    Health Technol Assess; 2016 Feb; 20(9):1-334, v-vi. PubMed ID: 26847392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).
    Kroon FP; van der Burg LR; Ramiro S; Landewé RB; Buchbinder R; Falzon L; van der Heijde D
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010952. PubMed ID: 26186173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in managing axial spondyloarthritis.
    Agrawal P; Machado PM
    F1000Res; 2020; 9():. PubMed ID: 32704350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey.
    Hunter T; Sandoval D; Booth N; Holdsworth E; Deodhar A
    Clin Rheumatol; 2021 Aug; 40(8):3161-3167. PubMed ID: 33611647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis.
    Atzeni F; Carriero A; Boccassini L; D'Angelo S
    Immunotargets Ther; 2021; 10():141-153. PubMed ID: 33977094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ankylosing spondylitis and non-radiographic axial spondyloarthritis in a multi-ethnic Asian population of Singapore.
    Hong C; Kwan YH; Leung YY; Lui NL; Fong W
    Int J Rheum Dis; 2019 Aug; 22(8):1506-1511. PubMed ID: 31090201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
    Malaviya AN; Kalyani A; Rawat R; Gogia SB
    Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Golimumab for the treatment of axial spondyloarthritis.
    Gelfer G; Perry L; Deodhar A
    Expert Rev Clin Immunol; 2016; 12(1):9-18. PubMed ID: 26523483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Immunomodulatory Therapies and New Treatment Paradigms for Axial Spondyloarthritis.
    Mease P
    Curr Rheumatol Rep; 2019 Jun; 21(7):35. PubMed ID: 31172311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.
    Dubash S; McGonagle D; Marzo-Ortega H
    Ther Adv Chronic Dis; 2018 Mar; 9(3):77-87. PubMed ID: 29511503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in ankylosing spondylitis-status in 2021.
    Klavdianou K; Tsiami S; Baraliakos X
    Rheumatology (Oxford); 2021 Dec; 60(Suppl 6):vi29-vi37. PubMed ID: 34951921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Janus Kinase Inhibitors: A New Tool for the Treatment of Axial Spondyloarthritis.
    Paroli M; Caccavale R; Paroli MP; Spadea L; Accapezzato D
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologics for treating axial spondyloarthritis.
    Jones A; Ciurtin C; Ismajli M; Leandro M; Sengupta R; Machado PM
    Expert Opin Biol Ther; 2018 Jun; 18(6):641-652. PubMed ID: 29681195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Failure in Axial Spondyloarthritis: Insights for a Standardized Definition.
    Juanola X; Ramos MJM; Belzunegui JM; Fernández-Carballido C; Gratacós J
    Adv Ther; 2022 Apr; 39(4):1490-1501. PubMed ID: 35201604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axial Spondyloarthritis: Reshape the Future-From the "2022 GISEA International Symposium".
    Salaffi F; Siragusano C; Alciati A; Cassone G; D'Angelo S; Guiducci S; Favalli EG; Conti F; Gremese E; Iannone F; Caporali R; Sebastiani M; Ferraccioli GF; Lapadula G; Atzeni F
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secukinumab in axial spondyloarthritis: a narrative review of clinical evidence.
    Braun J; Kiltz U; Bühring B; Baraliakos X
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211041854. PubMed ID: 34471428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.